Published in J Immunol Res on March 21, 2016
Dendritic cells and the control of immunity. Nature (1998) 56.54
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88
Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77
Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06
Plasmacytoid dendritic cells in immunity. Nat Immunol (2004) 9.11
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 7.58
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med (1974) 6.60
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A (2002) 6.19
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med (1998) 6.12
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med (1996) 6.11
The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol (2008) 4.86
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 4.75
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol (2002) 4.64
Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med (1982) 4.49
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today (1998) 4.21
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 4.02
The liver as an immunological organ. Hepatology (2006) 3.86
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81
Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med (2003) 3.74
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol (1995) 3.39
Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol (2011) 3.32
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother (2005) 3.20
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med (2002) 3.02
Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res (2005) 2.97
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood (1998) 2.93
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev (2006) 2.74
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med (2003) 2.65
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med (1999) 2.54
Cellular microparticles: what are they bad or good for? J Thromb Haemost (2003) 2.41
Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol (2010) 2.29
The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res (1998) 1.94
A novel pathway of alloantigen presentation by dendritic cells. J Immunol (2004) 1.94
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Immune tolerance: what is unique about the liver. J Autoimmun (2009) 1.79
T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res (2003) 1.79
Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J Exp Med (2006) 1.75
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett (2009) 1.60
Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res (2003) 1.59
Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol (1998) 1.57
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med (2011) 1.52
Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res (2001) 1.51
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol (2002) 1.49
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med (1992) 1.46
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol (2011) 1.41
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol Immunother (2008) 1.39
Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood (2010) 1.36
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother (2004) 1.31
Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res (1998) 1.29
Regulation of plasmacytoid dendritic cell development. Curr Opin Immunol (2010) 1.25
Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol (2000) 1.20
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br J Cancer (2003) 1.18
Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol (2004) 1.17
Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res (2010) 1.11
Dendritic cells, the liver, and transplantation. Hepatology (2007) 1.09
Tumor associated regulatory dendritic cells. Semin Cancer Biol (2012) 1.08
Cytokines in the generation and maturation of dendritic cells: recent advances. Eur Cytokine Netw (2002) 1.08
Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages. J Immunol (1985) 1.05
The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood (2007) 1.05
Maturation of function in dendritic cells for tolerance and immunity. J Cell Mol Med (2005) 1.02
Overcoming immunological barriers in regenerative medicine. Nat Biotechnol (2014) 1.02
Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol (2003) 1.01
Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online (2003) 0.97
CD4 T cells in hepatic immune tolerance. J Autoimmun (2009) 0.95
Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours. Br J Cancer (1999) 0.94
Paucity of dendritic cells in pancreatic cancer. Surgery (2002) 0.93
Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer (2002) 0.91
Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients. Cancer Res (2000) 0.84
Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome. Kidney Int (2011) 0.84
The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation. Kidney Int (2012) 0.83
Leukemic cell products down-regulate human dendritic cell differentiation. Cancer Immunol Immunother (2010) 0.83
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. J Urol (2003) 0.80
Human dendritic cells induce tumor-specific apoptosis by soluble factors. Int J Cancer (2002) 0.80
CD11c+ Dendritic Cells Accelerate the Rejection of Older Cardiac Transplants via Interleukin-17A. Circulation (2015) 0.79
Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation. Methods Mol Biol (2011) 0.78
Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β. Hum Immunol (2014) 0.77